Control and severity: complementary approaches to asthma management

High‐sensitivity C‐reactive protein: A predicative marker in severe asthma

“…Following the latest 2006 GINA guidelines, symptom control has been advocated as the key strategy for asthma management. Indeed, the level of asthma symptoms cannot be interpreted consistently in cross‐sectional surveys of asthmatic populations, which may not therefore be the best approach for epidemiological studies 31 . Further follow‐up cohort studies are needed to confirm the current findings by periodically assessing asthma control and prospectively measuring hs‐CRP levels.…”

GINA 2015: the latest iteration of a magnificent journey

“…The first asthma guidelines have been published in Australasia, UK [1] and the USA [2]. Canadian and French recommendations proposed the concept of control [3,4], and the National Asthma Education and Prevention Program Expert Panel Report initiated the concept of risk for asthma [5]. However, GINA is globally considered to be the prominent asthma recommendation building on existing knowledge and providing several updates or revisions since it was introduced in 1995 [2,6,7].…”

Control of asthma for reducing the risk of bronchospasm in asthmatics undergoing general anesthesia and/or intravascular administration of radiographic contrast media

“…However, considering the wide diversity of asthma phenotypes in clinical practice, each requiring different diagnostic/therapeutic approaches, and the fact that asthma control is not associated with asthma severity classification, it is evident that a careful clinical/functional evaluation is necessary [44][45][46] .…”